Cisplatin (Accord Healthcare, Inc.)
Welcome to the PulseAid listing for the Cisplatin drug offered from Accord Healthcare, Inc.. This Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Accord Healthcare, Inc. |
NON-PROPRIETARY NAME: | Cisplatin |
SUBSTANCE NAME: | CISPLATIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-12-13 |
END MARKETING DATE: | 0000-00-00 |
Cisplatin HUMAN PRESCRIPTION DRUG Details:
Item Description | Cisplatin from Accord Healthcare, Inc. |
LABELER NAME: | Accord Healthcare, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 2016-12-13 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 16729-288_43a22af4-12fc-640e-e054-00144ff88e88 |
PRODUCT NDC: | 16729-288 |
APPLICATION NUMBER: | ANDA206774 |
Other CISPLATIN Pharmaceutical Manufacturers / Labelers: